Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

被引:0
|
作者
Michael Kurnellas
Ananya Mitra
Tina Schwabe
Robert Paul
Andrew E. Arrant
Erik D. Roberson
Michael Ward
Felix Yeh
Hua Long
Arnon Rosenthal
机构
[1] Alector,Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, and Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology
[2] Inc.,undefined
[3] University of Alabama at Birmingham,undefined
[4] Neuron23,undefined
[5] Nine Square Therapeutics,undefined
[6] Inc.,undefined
[7] Genentech,undefined
来源
Journal of Translational Medicine | / 21卷
关键词
Frontotemporal dementia; Latozinemab; Neuroprotection; Phase 1 clinical trial; Pharmacodynamics; Pharmacokinetics; Progranulin; Safety; Sortilin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay
    Nguyen, Andrew D.
    Nguyen, Thi A.
    Zhang, Jiasheng
    Devireddy, Swathi
    Zhou, Ping
    Karydas, Anna M.
    Xu, Xialian
    Miller, Bruce L.
    Rigo, Frank
    Ferguson, Shawn M.
    Huang, Eric J.
    Walther, Tobias C.
    Farese, Robert V., Jr.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (12) : E2849 - E2858
  • [42] Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics
    Whitwell, Jennifer L.
    Weigand, Stephen D.
    Boeve, Bradley F.
    Senjem, Matthew L.
    Gunter, Jeffrey L.
    DeJesus-Hernandez, Mariely
    Rutherford, Nicola J.
    Baker, Matthew
    Knopman, David S.
    Wszolek, Zbigniew K.
    Parisi, Joseph E.
    Dickson, Dennis W.
    Petersen, Ronald C.
    Rademakers, Rosa
    Jack, Clifford R., Jr.
    Josephs, Keith A.
    BRAIN, 2012, 135 : 794 - 806
  • [43] TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations
    Seelaar, Harro
    Schelhaas, H. Jurgen
    Azmani, Asma
    Kusters, Benno
    Rosso, Sonia
    Majoor-Krakauer, Danielle
    de Rijk, Maarten C.
    Rizzu, Patrizia
    ten Brummelhuis, Ming
    van Doorn, Pieter A.
    Kamphorst, Wouter
    Willemsen, Rob
    van Swieten, John C.
    BRAIN, 2007, 130 : 1375 - 1385
  • [44] Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by GRN Mutations
    Holler, Christopher J.
    Taylor, Georgia
    Deng, Qiudong
    Kukar, Thomas
    ENEURO, 2017, 4 (04)
  • [45] Late onset bipolar disorder and frontotemporal dementia with mutation in progranulin gene: a case report
    Rubino, Elisa
    Vacca, Alessandro
    Gallone, Salvatore
    Govone, Flora
    Zucca, Milena
    Gai, Annalisa
    Ferrero, Patrizia
    Fenoglio, Pierpaola
    Giordana, Maria Teresa
    Rainero, Innocenzo
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 (7-8) : 624 - 626
  • [46] Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia
    Dols-Icardo, Oriol
    Suarez-Calvet, Marc
    Hernandez, Isabel
    Amer, Guillermo
    Anton-Aguirre, Sofia
    Alcolea, Daniel
    Fortea, Juan
    Boada, Merce
    Tarraga, Lluis
    Blesa, Rafael
    Lleo, Alberto
    Clarimon, Jordi
    NEUROBIOLOGY OF AGING, 2012, 33 (08) : 1851.e17 - 1851.e19
  • [47] Progranulin Gene Mutations in Chinese Patients with Frontotemporal Dementia: A Case Report and Literature Review
    Chu, Min
    Nan, Haitian
    Jiang, Deming
    Liu, Li
    Huang, Anqi
    Wang, Yihao
    Wu, Liyong
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 93 (01) : 225 - 234
  • [48] Reduced miR-659-3p Levels Correlate with Progranulin Increase in Hypoxic Conditions: Implications for Frontotemporal Dementia
    Piscopo, Paola
    Grasso, Margherita
    Fontana, Francesca
    Crestini, Alessio
    Puopolo, Maria
    Del Vescovo, Valerio
    Venerosi, Aldina
    Calamandrei, Gemma
    Vencken, Sebastian F.
    Greene, Catherine M.
    Confaloni, Annamaria
    Denti, Michela A.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2016, 9
  • [49] Increasing progranulin levels and blockade of the ERK1/2 pathway: Upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia
    Alquezar, Carolina
    Esteras, Noemi
    de la Encarnacion, Ana
    Moreno, Fermin
    Lopez de Munain, Adolfo
    Martin-Requero, Angeles
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (03) : 386 - 403
  • [50] Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience
    Sellami, Leila
    Rucheton, Benoit
    Ben Younes, Imen
    Camuzat, Agnes
    Saracino, Dario
    Rinaldi, Daisy
    Epelbaum, Stephane
    Azuar, Carole
    Levy, Richard
    Auriacombe, Sophie
    Hannequin, Didier
    Pariente, Jeremie
    Barbier, Mathieu
    Boutoleau-Bretonniere, Claire
    Couratier, Philippe
    Pasquier, Florence
    Deramecourt, Vincent
    Sauvee, Mathilde
    Sarazin, Marie
    Lagarde, Julien
    Roue-Jagot, Carole
    Forlani, Sylvie
    Jornea, Ludmila
    David, Isabelle
    LeGuern, Eric
    Dubois, Bruno
    Brice, Alexis
    Clot, Fabienne
    Lamari, Foudil
    Le Ber, Isabelle
    NEUROBIOLOGY OF AGING, 2020, 91 : 167.e1 - 167.e9